Reviews and feature articleMaternal farm exposure modulates neonatal immune mechanisms through regulatory T cells
Section snippets
Study population
We recruited pregnant mothers in an obstetric clinic in rural southern Germany in the frame of a birth cohort study (PAULCHEN). The population is representative of the subjects involved in previous farm studies.1, 3 Study enrollment through trained midwives occurred from July 2005 to September 2007 in the last trimester of pregnancy. Inclusion criteria comprised healthy neonates and mothers with uncomplicated pregnancies. Exclusion criteria included preterm deliveries, perinatal infections,
Population characteristics
Table I shows the characteristics of 82 included subjects (22 neonates of farming mothers and 60 of nonfarming mothers). Farming mothers smoked less and showed a trend toward less education compared with nonfarming mothers (P = .04 and .06, respectively). Both factors were tested for potential confounding but were revealed not to be confounders. Maternal atopy was less in farming mothers, although not significantly.
Treg cell numbers are quantitatively and qualitatively increased in cord blood of farming mothers
We assessed Treg cells by measuring the surface expression of CD4+CD25high T
Discussion
This study suggests a mechanism by which the protective effect of farming exposure in pregnancy might influence neonatal immune development and subsequently reduce the development of allergic diseases. Treg cells, comprehensively assessed in number, gene expression, epigenetic regulation, and function, were mainly at higher levels and more efficient in offspring of farming compared with nonfarming mothers after specific stimulation. This was associated with decreased TH2 cytokine levels and
References (32)
- et al.
Living on a farm: impact on Asthma Induction and Clinical Course
Immunol Allergy Clin North Am
(2008) - et al.
Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children
J Allergy Clin Immunol
(2006) - et al.
Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children
Lancet
(2002) - et al.
CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene
Exp Hematol
(2004) - et al.
Role of LAG-3 in regulatory T cells
Immunity
(2004) - et al.
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease
Lancet
(2004) - et al.
Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma
J Allergy Clin Immunol
(2004) - et al.
Th17: an effector CD4 T cell lineage with regulatory T cell ties
Immunity
(2006) - et al.
Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens
J Allergy Clin Immunol
(2006) - et al.
Possible pathogenic role of Th17 cells for atopic dermatitis
J Invest Dermatol
(2008)
Environmental exposure to endotoxin and its relation to asthma in school-age children
N Engl J Med
Toll-like receptor 4 or 2 agonists decrease allergic inflammation
Am J Respir Cell Mol Biol
Regulatory T cells as potential immunotherapy in allergy
Curr Opin Allergy Clin Immunol
Foxp3-dependent programme of regulatory T-cell differentiation
Nature
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Nat Immunol
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
J Exp Med
Cited by (358)
A perspective on green, blue, and grey spaces, biodiversity, microbiota, and human health
2023, Science of the Total EnvironmentFrom Amish farm dust to bacterial lysates: The long and winding road to protection from allergic disease
2023, Seminars in ImmunologyWhat Have Mechanistic Studies Taught Us About Childhood Asthma?
2023, Journal of Allergy and Clinical Immunology: In PracticeImmunology of the Fetus and Newborn
2023, Avery's Diseases of the NewbornAn integrated molecular risk score early in life for subsequent childhood asthma risk
2024, Clinical and Experimental Allergy
Supported by Stiftung OMNIBUS, Friedrich-Baur Institut, Münchner Universitätsgesellschaft, Bayerische Forschungsstiftung (PIZ-140-08) (B.S.), and DFG SFB650 (J.H.).
Disclosure of potential conflict of interest: S. Olek is an employee and stockholder of Epiontis. The rest of the authors have declared that they have no conflict of interest.
- ∗
These authors contributed equally to this work.